Lipitor’s sales halved by new generic competition
December 19, 2011 at 11:30 am in Grand Forks Herald
That’s despite a very aggressive effort by Lipitor maker Pfizer Inc. to keep patients on its pill, which generated peak sales of $13 billion a year, through patient subsidies and big rebates to insurers. Lipitor lost patent protection on Nov. 30 in the U.S. Continue Reading
1. Allowing third-world-sourced prescription drugs into the USA is a huge mistake.
2. America would be better off if 2/3 of all current prescription drugs were made available without a prescription.
3. America was better off before our government allowed advertising for prescription medications in consumer media.
4. Since prescription medications typically cost more here than in any other country on earth, it’s time to investigate the pharmaceutical industry for price fixing. Those convicted should face prison time, not merely “fines”.
Like or Dislike:
1 
0